Taken together, the function of NKG2D is expressed as a marker of NK cell activation in liver steatosis-associated metabolic diseases; its increased expression is closely related to the activated state of NK cells and plays a role in immune and inflammatory responses during the development of liver steatosis. Here, KLRK1 is linked to metabolic disease.